Autonomix Medical, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
AMIX Nasdaq 3840 autonomix.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Autonomix Medical, Inc.

Autonomix Medical to Present at LSI USA ’26 - Mar 11th, 2026 6:40 am
Autonomix Medical Selected for Best Innovation Competition at CRT 2026 - Mar 5th, 2026 6:45 am
Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis - Mar 4th, 2026 6:40 am
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Publication Strategy and Scientific Validation - Feb 25th, 2026 6:30 am
Autonomix Medical Selected to Present New Long-Term Pain Mitigation Data in Pancreatic Cancer at SSO 2026 Annual Meeting in Podium Presentation - Feb 19th, 2026 6:30 am
Autonomix Medical to Present Final Analysis on Pain Mitigation in Pancreatic Cancer at SIO 2026 Annual Scientific Meeting - Jan 28th, 2026 6:30 am
Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium - Jan 9th, 2026 6:45 am
BC-Most Active Stocks - Dec 30th, 2025 8:30 am
Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology - Dec 30th, 2025 6:30 am
Autonomix Medical, Inc. (NASDAQ: AMIX) Highlights Expanding IP Portfolio and Multi-Indication Platform Strategy in Virtual Investor CEO Connect Segment - Dec 23rd, 2025 6:45 am
Autonomix Medical, Inc. Announces Abstract Selected for Poster Presentation at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium - Dec 18th, 2025 6:30 am
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth - Nov 26th, 2025 6:45 am
Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced At The Market Under Nasdaq Rules - Nov 18th, 2025 6:30 am
Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC Study - Nov 17th, 2025 6:00 am
Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference - Oct 24th, 2025 7:00 am
Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit - Oct 16th, 2025 7:15 am
Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology - Oct 9th, 2025 6:45 am
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment - Oct 2nd, 2025 6:45 am
Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System - Sep 29th, 2025 7:15 am
Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2025 CIRSE Annual Congress - Sep 9th, 2025 7:00 am